{"id":256162,"date":"2023-05-16T12:43:56","date_gmt":"2023-05-16T10:43:56","guid":{"rendered":"https:\/\/www.fqeuskadi.org\/?p=256162"},"modified":"2023-05-16T12:44:01","modified_gmt":"2023-05-16T10:44:01","slug":"fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako","status":"publish","type":"post","link":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/","title":{"rendered":"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen (ivacaftor) hilabete bat eta, Kalydecora sentikortasuna frogatu duten 97 mutazioko kopia bat duten haurrentzat.<\/h3>\n

AEBetako Drogen eta Elikagaien Administrazioa. (FDA)-k Kalydeco \u00ae (ivacaftor) onartu zuen, 1-4 hilabeteko<\/b> Fibrosi Kistikoa duten eta mutazio batzuk dituzten haurrentzako. Onespen horrek haur gutxi batzuei eragiten badie ere, beste urrats garrantzitsu bat<\/b> da FKa duten pertsona guztiek beren gaixotasunaren kausarako tratamendua jasoko dutela bermatzeko.<\/p>\n

\n

Kalydeco eta antzeko moduladoreek partzialki berrezartzen dute<\/b> Fibrosi Kistikoaren (CFTR) mintzezko konduktantzia erregulatzen duen proteinaren jarduera, zeinak gatzaren eta likidoen oreka egokia mantentzen baitu<\/b> biriketako eta beste organo batzuetako gainazaletan. Ikerketek erakutsi dutenez, pankrearen funtzioa berrezarri<\/b> egin daiteke Kalydeco hartzen duten haur txiki batzuetan.<\/p>\n<\/blockquote>\n

KALYDECO<\/h3>\n

Kalydeco onartu zen, hasiera batean, 2012an, 6 urtetik gorako pertsonen tratamendurako G551D mutazioarekin, AEBetan FKa duten ia 40 000 pertsonen % 4.<\/b> Harrezkeroztik, onespena 97 mutazioetako batekinbat duten lau hilabeteko haurretara zabaldu da.<\/p>\n

Kalydeco Vertex Pharmaceuticals Inc.<\/b> enpresak garatu zuen, Cystic Fibrosis Foundation-en laguntza kliniko, zientifiko eta finantzario garrantzitsuarekin.<\/p>\n

FKa duten pertsonei bizitza luzeagoa eta osasungarriagoa izaten laguntzeko aurrerapen handia <\/b>egin den arren, pertsona batzuk ez dira hautagarriak modulatzaile bat hartzeko edo ez dute sendagaia onartzen. Oraindik lan kritiko bat<\/b> egin behar da FKarekin bizi diren pertsona guztiei beren gaixotasunaren kausarako tratamendu bat lortzen laguntzeko.<\/p>\n

Jatorrizko albistea<\/a><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen (ivacaftor) hilabete bat eta, Kalydecora sentikortasuna frogatu duten 97 mutazioko kopia bat duten haurrentzat. AEBetako Drogen eta Elikagaien Administrazioa. (FDA)-k Kalydeco \u00ae (ivacaftor) onartu zuen, 1-4 hilabeteko Fibrosi Kistikoa duten eta mutazio batzuk dituzten haurrentzako. Onespen horrek haur gutxi batzuei eragiten badie ere, beste urrats garrantzitsu […]<\/p>\n","protected":false},"author":1,"featured_media":256153,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[47],"tags":[],"class_list":["post-256162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fq-berriak"],"yoast_head":"\nFDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako<\/title>\n<meta name=\"description\" content=\"AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen hilabete bat eta, Kalydecora sentikortasuna duten 97 mutazioentzat.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako\" \/>\n<meta property=\"og:description\" content=\"AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen hilabete bat eta, Kalydecora sentikortasuna duten 97 mutazioentzat.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\" \/>\n<meta property=\"og:site_name\" content=\"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fqeuskadi\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-16T10:43:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-16T10:44:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fqeuskadi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@fqeuskadi\" \/>\n<meta name=\"twitter:site\" content=\"@fqeuskadi\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fqeuskadi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutua\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\"},\"author\":{\"name\":\"fqeuskadi\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81\"},\"headline\":\"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako\",\"datePublished\":\"2023-05-16T10:43:56+00:00\",\"dateModified\":\"2023-05-16T10:44:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\"},\"wordCount\":282,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg\",\"articleSection\":[\"FQ BERRIAK\"],\"inLanguage\":\"eu\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\",\"url\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\",\"name\":\"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako\",\"isPartOf\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg\",\"datePublished\":\"2023-05-16T10:43:56+00:00\",\"dateModified\":\"2023-05-16T10:44:01+00:00\",\"description\":\"AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen hilabete bat eta, Kalydecora sentikortasuna duten 97 mutazioentzat.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#breadcrumb\"},\"inLanguage\":\"eu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage\",\"url\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg\",\"contentUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg\",\"width\":600,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.fqeuskadi.org\/eu\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#website\",\"url\":\"https:\/\/www.fqeuskadi.org\/\",\"name\":\"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI\",\"description\":\"FQ Euskadi trabaja por las personas con Fibrosis qu\u00edstica. Desde Fq Euskadi ayudamos con nuestra labor y servicios a unas 90 familias con FQ.\",\"publisher\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fqeuskadi.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\",\"name\":\"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI\",\"url\":\"https:\/\/www.fqeuskadi.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg\",\"contentUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg\",\"width\":1950,\"height\":532,\"caption\":\"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/fqeuskadi\/\",\"https:\/\/x.com\/fqeuskadi\",\"https:\/\/www.instagram.com\/fqeuskadi\/\",\"https:\/\/www.youtube.com\/channel\/UCyqLMZSfydAklJH1x-Js97w\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81\",\"name\":\"fqeuskadi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g\",\"caption\":\"fqeuskadi\"},\"description\":\"Asociaci\u00f3n dedicada a la mejora de la calidad de vida de las personas con fibrosis quistica fqeuskadi\",\"sameAs\":[\"https:\/\/www.fqeuskadi.org\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako","description":"AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen hilabete bat eta, Kalydecora sentikortasuna duten 97 mutazioentzat.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/","og_locale":"en_US","og_type":"article","og_title":"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako","og_description":"AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen hilabete bat eta, Kalydecora sentikortasuna duten 97 mutazioentzat.","og_url":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/","og_site_name":"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI","article_publisher":"https:\/\/www.facebook.com\/fqeuskadi\/","article_published_time":"2023-05-16T10:43:56+00:00","article_modified_time":"2023-05-16T10:44:01+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg","type":"image\/jpeg"}],"author":"fqeuskadi","twitter_card":"summary_large_image","twitter_creator":"@fqeuskadi","twitter_site":"@fqeuskadi","twitter_misc":{"Written by":"fqeuskadi","Est. reading time":"2 minutua"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#article","isPartOf":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/"},"author":{"name":"fqeuskadi","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81"},"headline":"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako","datePublished":"2023-05-16T10:43:56+00:00","dateModified":"2023-05-16T10:44:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/"},"wordCount":282,"commentCount":0,"publisher":{"@id":"https:\/\/www.fqeuskadi.org\/#organization"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg","articleSection":["FQ BERRIAK"],"inLanguage":"eu","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/","url":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/","name":"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako","isPartOf":{"@id":"https:\/\/www.fqeuskadi.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg","datePublished":"2023-05-16T10:43:56+00:00","dateModified":"2023-05-16T10:44:01+00:00","description":"AEBko Drogen eta Elikagaien Administrazioak, Kalydeco \u00ae onartu zuen hilabete bat eta, Kalydecora sentikortasuna duten 97 mutazioentzat.","breadcrumb":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#breadcrumb"},"inLanguage":"eu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/"]}]},{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#primaryimage","url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg","contentUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2023\/05\/KALYDECO-ID-47.jpg","width":600,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.fqeuskadi.org\/eu\/fdak-kalydeco-onartu-du-hilabete-batetik-aurrerako-haurrentzako\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.fqeuskadi.org\/eu\/home\/"},{"@type":"ListItem","position":2,"name":"FDAk Kalydeco onartu du hilabete batetik aurrerako haurrentzako"}]},{"@type":"WebSite","@id":"https:\/\/www.fqeuskadi.org\/#website","url":"https:\/\/www.fqeuskadi.org\/","name":"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI","description":"FQ Euskadi trabaja por las personas con Fibrosis qu\u00edstica. Desde Fq Euskadi ayudamos con nuestra labor y servicios a unas 90 familias con FQ.","publisher":{"@id":"https:\/\/www.fqeuskadi.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fqeuskadi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu"},{"@type":"Organization","@id":"https:\/\/www.fqeuskadi.org\/#organization","name":"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI","url":"https:\/\/www.fqeuskadi.org\/","logo":{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg","contentUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg","width":1950,"height":532,"caption":"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fqeuskadi\/","https:\/\/x.com\/fqeuskadi","https:\/\/www.instagram.com\/fqeuskadi\/","https:\/\/www.youtube.com\/channel\/UCyqLMZSfydAklJH1x-Js97w"]},{"@type":"Person","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81","name":"fqeuskadi","image":{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g","caption":"fqeuskadi"},"description":"Asociaci\u00f3n dedicada a la mejora de la calidad de vida de las personas con fibrosis quistica fqeuskadi","sameAs":["https:\/\/www.fqeuskadi.org"]}]}},"_links":{"self":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts\/256162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/comments?post=256162"}],"version-history":[{"count":3,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts\/256162\/revisions"}],"predecessor-version":[{"id":256169,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts\/256162\/revisions\/256169"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/media\/256153"}],"wp:attachment":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/media?parent=256162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/categories?post=256162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/tags?post=256162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}